insights_auto
Bakit bumaba ang 524494 3.51%?
Tingnan ang Higit pang Detalyechevron_right
524494:BOM
IPCA Laboratories Ltd
₹1,845.00
arrow_downward
-3.51%(-67.20) 1D
Okt 16, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 524494...
Buksan
₹1,913.95
Mataas
₹1,913.95
Mababa
₹1,812.60
Mkt. cap
468.21B
Avg. na dami
27.90K
Dami
0.00
Dividend
0.33%
Bawat tatlong buwang dividend
₹1.50
Petsa ng ex-dividend
Ago 7, 2026
P/E ratio
35.74
Mataas nang 52-wk
₹2,039.30
Mababa nang 52-wk
₹1,252.95
EPS
₹51.63
Mga natitirang share
126.35M
Bilang ng mga empleyado
17K
Buksan
₹1,913.95
Mataas
₹1,913.95
Mababa
₹1,812.60
Mkt. cap
468.21B
Avg. na dami
27.90K
Dami
0.00
Dividend
0.33%
Bawat tatlong buwang dividend
₹1.50
Petsa ng ex-dividend
Ago 7, 2026
P/E ratio
35.74
Mataas nang 52-wk
₹2,039.30
Mababa nang 52-wk
₹1,252.95
EPS
₹51.63
Mga natitirang share
126.35M
Bilang ng mga empleyado
17K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketWatch
·
13 oras ang nakalipas
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
The Motley Fool
·
15 oras ang nakalipas
We Just Witnessed a Unique Stock Market Measure Do Something for Only the 4th Time Since 1997, and It Offers a Chilling Outlook for Wall Street
Bloomberg.com
·
1 linggo ang nakalipas
S&P 500 Wavers as Earnings Bets Offset Chip Rout: Markets Wrap
Reuters
·
5 araw ang nakalipas
Nasdaq ends down as chipmakers fall and bank earnings roll in
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Tungkol sa IPCA Laboratories Ltd